Building Critical Healthcare Technologies for National Security and Resilience

Appili was created to acquire, develop, and advance medical products and technologies that protect military personnel, strengthen national resilience, and address critical healthcare needs. 

Accelerating National Security and Resilience Solutions

Advancing medical products and technologies across biodefense, infectious disease, physiological readiness, diagnostics, biosurveillance, and other high-priority healthcare needs

experienceD Leadership team

Leadership team skilled in advancing
programs with upside potential

partnering with Appili

Active partnering and in-licensing efforts to expand clinical programs and accelerate commercialization

OUR STRATEGIC POSITIONING

Bridging the Gap in Biodefence Innovation

Appili is positioned at the intersection of commercial pharmaceutical expertise and specialized biodefence innovation

CIVILIAN MARKET REACH →

Pfizer logo
Lilly logo

Big Pharma

Appili Therapeutics logo
Yale University logo
UMass Chan Medical School logo

Academic Biodefence Research

Elusys Therapeutics logo
Emergent BioSolutions logo

Legacy Biodefence Companies

MILITARY & DEFENCE DEPTH →
 

The PROBLEM: U.S. Biodefense Shield is Brittle and Aging

Geopolitical Tension is Rising

Ongoing wars in Eastern-Europe and the Middle-East grow the demand for countermeasures, but many remain stalled at the R&D stage

Major Gaps in the Modern Battlefield

Prolonged field care, combined with hemorrhage, sepsis risk and AI-driven warfare call for solutions                          

Outdated & Weak Stockpile Supply Chains

Strategic biodefense lean on a handful of legacy products from single sources

                                          

Dysfunctional Commercial Incentives

Pureplay biodefense products have long sales cycles, a single buyer and suffer from “pen stroke risk”

                                         

Innovation Across a Broad Spectrum of Medical Countermeasures

ATI-1801

A novel topical antiparasitic product to treat disfiguring skin infections around the world

ATI-1701

A potential first-in-class live-attenuated vaccine for tularemia, a serious biothreat

LIKMEZ® (ATI-1501)

A novel oral taste-masked suspension of metronidazole to treat serious anaerobic and protozoal infections

Discover the safest and most reliable platforms on the PAGCOR online casino list, expertly curated by the trusted team at casino10 Philippines.

Experience top-tier gaming with our partners Mission Uncrossable, Chicken Road, and Plinko, alongside the best European online casinos and Crown Casino Online Australia real money.